Browsing by Author "Yildiz, Yasar"
Now showing items 1-2 of 2
-
Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less
Ozaslan, Ersin; Karaca, Halit; Koca, Sinan; Sevinc, Alper; Hacioglu, Bekir; Ozkan, Metin; Ozcelik, Melike; Duran, Ayse O.; Hacibekiroglu, Ilhan; Yildiz, Yasar; Tanriverdi, Ozgur; Menekse, Serkan; Aksoy, Asude; Bozkurt, Oktay; Urvay, Semiha; Uysal, Mukremin; Demir, Hacer; Ciltas, Aydin; Dane, Faysal (LIPPINCOTT WILLIAMS & WILKINS, 2017)The objectives of this study were to compare progression-free survival (PFS) with somatostatin analog (SSA) versus chemotherapy (CTx) in first-line therapy and to determine the patient group in which these treatments were ... -
Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas
Cicin, Irfan; Ozatli, Tahsin; Turkmen, Esma; Ozturk, Turkan; Ozcelik, Melike; Cabuk, Devrim; Gokdurnali, Ayse; Balvan, Ozlem; Yildiz, Yasar; Seker, Metin; Ozdemir, Nuriye; Yapar, Burcu; Tanriverdi, Ozgur; Gunaydin, Yusuf; Menekse, Serkan; Oksuzoglu, Berna; Aksoy, Asude; Erdogan, Bulent; Hacioglu, M. Bekir; Arpaci, Erkan; Sevinc, Alper (GALENOS YAYINCILIK, 2016)Background: Prognostic factors and the standard treatment approach for gynaecological carcinosarcomas have not yet been clearly defined. Although carcinosarcomas are more aggressive than pure epithelial tumours, they are ...